Bellvitge University Hospital

Futó vizsgálatok

• Még nem toboroz

  A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis

  NCT07335562· 3. fázis· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Forrás

• Még nem toboroz

  A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)

  NCT07915219· 3. fázis· Boehringer Ingelheim· Forrás

• Még nem toboroz

  A study to compare heart failure medicines in one combined pill with usual care.

  2026-526510-90-00· 3. fázis· Institut De Recherches Internationales Servier IRIS· Forrás

• Még nem toboroz

  A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment

  NCT07926321· 2. fázis· Boehringer Ingelheim· Forrás

• Még nem toboroz

  A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis

  NCT07873801· 3. fázis· Almirall, S.A.· Forrás

• Még nem toboroz

  To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)

  NCT07116473· 3. fázis· Eidos Therapeutics, a BridgeBio company· Forrás

• Toboroz

  Study of an Injectable Regimen of GS-3242 with Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment

  2026-526026-40-00· 2/3. fázis· Gilead Sciences Inc.· Forrás

• Toboroz

  Albuminuria Reduction Trial and Investigation with Survodutide Treatment in CKD (ARTIST-CKD)

  2025-525068-13-00· 2. fázis· Universitair Medisch Centrum Groningen· Forrás

• Toboroz

  A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy (KINSHIP-OLE).

  2026-526139-20-00· 3. fázis· Kardigan Inc.· Forrás

• Toboroz

  Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360

  NCT07323316· Ad scientiam· Forrás

• Toboroz

  Study evaluating the efficacy and safety of daridorexant in patients with major depressive disorder and insomnia.

  2025-524794-16-00· 4. fázis· Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL· Forrás

• Toboroz

  A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07465289· 3. fázis· UCB Biopharma SRL· Forrás

• Még nem toboroz

  A Phase 2, randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of CRD-4730 in patients with heart failure with reduced ejection fraction (HFREF) (CALIBRATE-HF)

  2025-525033-31-00· 2. fázis· Cardurion Pharmaceuticals Inc.· Forrás

• Toboroz

  A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)

  2025-525016-41-00· 2. fázis· AstraZeneca AB· Forrás

• Toboroz

  Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

  2025-524335-39-00· 3. fázis· Gilead Sciences Inc.· Forrás

• Toboroz

  A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

  NCT07771465· 3. fázis· Kardigan, Inc.· Forrás

• Toboroz

  A study to find out if enfortumab vedotin given with pembrolizumab helps people with muscle-invasive bladder cancer keep their bladder.

  2025-524488-18-00· 2. fázis· Astellas Pharma Global Development Inc.· Forrás

• Toboroz

  ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

  NCT06716021· 3. fázis· Milestone Pharmaceuticals Inc.· Forrás

• Toboroz

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A study to check whether adding RUTI® to standard BCG treatment for high-risk early-stage bladder cancer is safe and how it changes the body’s defenses, with participants randomly receiving RUTI® or a look-alike treatment.

  2026-525897-20-00· 1. fázis· Laboratorio Reig Jofre S.A.· Forrás

• Toboroz

  A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

  NCT07516951· 2. fázis· Chiesi Farmaceutici S.p.A.· Forrás

• Toboroz

  Spanish Prospective Registry of Hydra THV for Transcatheter Aortic Valve Implantation

  NCT07566624· Fundación EPIC· Forrás

• Toboroz

  Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis

  NCT07695701· 4. fázis· Eidos Therapeutics, a BridgeBio company· Forrás

• Még nem toboroz

  Evaluation of Calcified Coronary Lesion Preparation With the Naviscore Scoring Balloon

  NCT07650578· University of Mons· Forrás

• Toboroz

  A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

  NCT07650916· 3. fázis· ViiV Healthcare· Forrás

• Toboroz

  A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma (SOLAIRIA-1)

  2025-524040-35-00· 3. fázis· Generate Biomedicines Inc.· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07463521· 3. fázis· UCB Biopharma SRL· Forrás

• Toboroz

  A Phase 3 Trial of K-924 HD in Participants with Hypercholesterolemia with Inadequate Response to EU-Marketed Pitavastatin 4 mg

  2025-523739-20-00· 3. fázis· Kowa Co. Ltd.· Forrás

• Toboroz

  A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis

  NCT07571174· 1. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS)

  NCT07571200· 1. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS)

  2025-524002-16-00· 3. fázis· Ferrer Internacional S.A.· Forrás

• Még nem toboroz

  REACTION-VAD Trial: Remote Exercise Training Via Telemedicine in Patients With Long-Term Ventricular Assist Devices

  NCT07611188· Puerta de Hierro University Hospital· Forrás

• Még nem toboroz

  Retinal Ganglion Cell Neuroprotection Under Prostaglandin Analogues

  NCT07074782· Association for Innovation and Biomedical Research on Light and Image· Forrás

• Toboroz

  A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)

  NCT07221669· 3. fázis· Biogen· Forrás

• Toboroz

  A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis

  2025-521546-23-00· 3. fázis· Novartis Pharma AG· Forrás

• Toboroz

  Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria

  2025-522878-36-00· 3. fázis· Celldex Therapeutics Inc.· Forrás

• Még nem toboroz

  PRIME Trial - Primary Respiratory Infection and Microbiological Eradication Trial

  2025-524454-34-00· 4. fázis· Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau· Forrás

• Még nem toboroz

  Efficacy and Safety of Daridorexant in Patients With Major Depressive Disorder and Insomnia

  NCT07555743· 4. fázis· Institut d'Investigació Biomèdica de Bellvitge· Forrás

• Meghívásos bevonás

  A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma

  NCT07338968· 3. fázis· Aura Biosciences· Forrás

• Toboroz

  A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

  NCT07326709· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)

  NCT07282574· 2. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF

  NCT07194382· 2. fázis· Avalyn Pharma Inc.· Forrás

• Még nem toboroz

  Combined impact of cardiovascular polypill treatment and a specific nurse education program on adherence to therapy in patients with ACS: a randomized study

  2025-524751-32-00· 4. fázis· Fundacion Epic· Forrás

• Toboroz

  A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy.

  2025-522553-19-00· 2/3. fázis· Kardigan Inc.· Forrás

• Toboroz

  A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

  NCT07361302· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

  NCT07210723· 2/3. fázis· Kardigan, Inc.· Forrás

• Toboroz

  A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

  NCT07202546· 2. fázis· ViiV Healthcare· Forrás

• Toboroz

  TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

  NCT07223203· 3. fázis· Alnylam Pharmaceuticals· Forrás

• Toboroz

  Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

  NCT07322003· 3. fázis· Prilenia· Forrás

• Még nem toboroz

  Comparison of Transmesocolic Versus Retromesenteric Reconstruction in Cephalic Duodenopancreatectomy (FAST Trial)

  NCT07368218· Hospital Universitari de Bellvitge· Forrás

Showing 50 of 208.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Szívelégtelenség15 toboroz
• Koszorúér-betegség8 toboroz
• Amiotrófiás laterálszklerózis (ALS)7 toboroz
• Amiloidózis6 toboroz
• Stroke (szélütés)6 toboroz
• Aortic stenosis5 toboroz
• Dilated cardiomyopathy5 toboroz
• HIV-fertőzés5 toboroz
• Myasthenia gravis5 toboroz
• Bronchiectasis4 toboroz
• Idiopátiás tüdőfibrózis4 toboroz
• Időskori makuladegeneráció4 toboroz
• Depresszió3 toboroz
• Elhízás3 toboroz
• Hasnyálmirigyrák3 toboroz
• Hólyagrák3 toboroz
• Pitvarfibrilláció3 toboroz
• Prosztatarák3 toboroz
• Sclerosis multiplex (SM)3 toboroz
• Asztma2 toboroz
• Atópiás dermatitisz (ekcéma)2 toboroz
• Gyomor- és nyelőcsőrák2 toboroz
• Huntington-kór2 toboroz
• Insomnia2 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)2 toboroz
• Krónikus vesebetegség2 toboroz
• Melanóma2 toboroz
• Myocarditis2 toboroz
• Neuroendokrin daganatok2 toboroz
• Szisztémás szklerózis (szkleroderma)2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• ANCA-asszociált vasculitis1 toboroz
• Aortic aneurysm1 toboroz
• Áttétes emlőrák1 toboroz
• Bipoláris zavar1 toboroz
• Chronic spontaneous urticaria1 toboroz
• Cisztás fibrózis1 toboroz
• Colitis ulcerosa1 toboroz
• Crohn-betegség1 toboroz
• Dermatomyositis and polymyositis (myositis)1 toboroz
• Diabéteszes retinopátia1 toboroz
• Epilepszia1 toboroz
• Familiáris hiperkoleszterinémia1 toboroz
• Gastroparesis1 toboroz
• Gyermekkori daganatok1 toboroz
• Hipertrófiás kardiomiopátia1 toboroz
• Hypothyroidism1 toboroz
• Magas vérnyomás1 toboroz
• Méhtestrák1 toboroz
• Migrén1 toboroz
• Nephrotic syndrome1 toboroz
• Petefészekrák1 toboroz
• Spinális izomatrófia (SMA)1 toboroz
• Tüdőrák1 toboroz
• Vastagbélrák1 toboroz
• Zöldhályog (glaukóma)1 toboroz

Lezárt vizsgálatok

• Fut, nem toboroz

  An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps

  NCT07424144· 3. fázis· Sanofi· Forrás

• Toboroz

  Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS

  NCT07287397· 1/2. fázis· Vector Y Therapeutics· Forrás

• Fut, nem toboroz

  Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)

  NCT06931405· 2. fázis· Blueprint Medicines Corporation· Forrás

• Lezárult

  A Phase 2b, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of JNJ-95475939 for the Treatment of Participants with Moderate to Severe Atopic Dermatitis

  2024-517814-13-00· 2. fázis· Janssen Cilag International· Forrás

• Lezárult

  Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed

  NCT06544733· 2/3. fázis· Gilead Sciences Inc.· Forrás

• Toboroz

  A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

  NCT06717698· 2. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Idiopathic Generalized Epilepsy with Generalized Tonic-clonic Seizures – SHINE

  NCT06425159· 2/3. fázis· Biohaven Therapeutics Ltd.· Forrás

• Lezárult

  Sapphire 3 CTO Study

  NCT06358508· OrbusNeich· Forrás

• Lezárult

  Phase 2 study to evaluate the efficacy and safety of GSK3915393 in participants with Idiopathic Pulmonary Fibrosis (IPF)

  NCT06317285· 2. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Lezárult

  A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis

  2023-510249-79-00· 2. fázis· Boehringer Ingelheim International GmbH· Forrás

• Lezárult

  A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT06335303· 2. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease

  NCT06522997· 2. fázis· Bayer· Forrás

• Lezárult

  A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF)

  2023-506185-31-00· 2/3. fázis· Pliant Therapeutics Inc.· Forrás

• Lezárult

  Validation of a Score for Supplementation Needs of Vitamins, Micronutrients and Proteins After Bariatric Surgery

  NCT07268209· Hospital Universitari de Bellvitge· Forrás

• Lezárult

  Evaluating efficacy and safety of switching a boosted protease inhibitor to fostemsavir in PLWH with limited therapeutic options (FOST Switch)

  2023-504192-25-00· 4. fázis· NEAT ID Foundation· Forrás

• Lezárult

  A Study to Learn How Safe Starting Vericiguat at a Dose of 5 Milligrams is in Participants With Chronic Heart Failure With Reduced Ejection Fraction

  NCT06195930· 2. fázis· Bayer· Forrás

• Lezárult

  Comparison of three short rifamycin-based regimens to treat latent tuberculosis in patients with end-stage kidney disease.

  2023-506432-32-00· 4. fázis· Bellvitge University Hospital· Forrás

• Lezárult

  A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo

  NCT06131372· 2. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  A Phase 1b, Open-Label, Multiple Ascending Dose, Multicenter Study of VRG50635 in Participants With Sporadic and Familial Amyotrophic Lateral Sclerosis Followed by Long-Term Treatment

  2023-506509-21-00· 1. fázis· Verge Genomics· Forrás

• Fut, nem toboroz

  A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)

  NCT06282159· 2. fázis· Dianthus Therapeutics· Forrás

• Lezárult

  A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis

  NCT06280391· 2. fázis· Sanofi· Forrás

• Lezárult

  THE ANTES B+ STUDY: AN OPEN-LABEL, PRAGMATIC, RANDOMIZED, CONTROLLED TRIAL OF TRIPLE THERAPY VERSUS LABA-LAMA COMBINATION TO IMPROVE CLINICAL CONTROL IN HIGH-RISK GOLD B PATIENTS (B+)

  2023-507304-32-00· 4. fázis· Fundacio Privada Mon Clinic Barcelona· Forrás

• Lezárult

  Cough Reduction in IPF With Nalbuphine ER

  NCT05964335· 2. fázis· Trevi Therapeutics· Forrás

• Lezárult

  Impact of the Implementation of a Telemedicine Program on Patients Diagnosed With Asthma

  NCT06116292· Hospital Universitari de Bellvitge· Forrás

• Fut, nem toboroz

  MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

  NCT06132256· 2. fázis· Syndax Pharmaceuticals· Forrás

• Leállították

  A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)

  NCT06113328· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Leállították

  Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

  NCT06097260· 2. fázis· Pliant Therapeutics, Inc.· Forrás

• Fut, nem toboroz

  Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

  NCT06122779· 2. fázis· Bristol-Myers Squibb· Forrás

• Lezárult

  Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults

  NCT06039579· 2. fázis· ViiV Healthcare· Forrás

• Lezárult

  A Phase 3, Double-blind Maintenance Study Assessing Rocatinlimab in Moderate-to-severe AD (ROCKET-ASCEND)

  NCT05882877· 3. fázis· Amgen Inc.· Forrás

• Lezárult

  A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis

  NCT05923099· 2. fázis· LEO Pharma· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Vixarelimab Compared with Placebo in Patients with Idiopathic Pulmonary Fibrosis and in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

  2022-502828-42-00· 2. fázis· Genentech Inc.· Forrás

• Lezárult

  A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke

  NCT05953480· 2. fázis· Shionogi· Forrás

• Lezárult

  Phase 2b Study to Assess Efficacy and Safety of Batoclimab in Adult Participants with Active CIDP.

  2024-512646-42-00· 2. fázis· Immunovant Sciences GmbH· Forrás

• Lezárult

  A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis

  NCT05507580· 4. fázis· AbbVie· Forrás

• Lezárult

  A Phase 2 Study of the Effects of Ponsegromab on Health-Related Quality of Life and Safety in Patients With Heart Failure (GARDEN-TIMI 74)

  NCT05492500· 2. fázis· Pfizer Inc.· Forrás

• Lezárult

  A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Cardiomyopathy

  NCT05582395· 3. fázis· Myokardia Inc.· Forrás

• Lezárult

  Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients

  NCT05586971· 3. fázis· LG Chem· Forrás

• Lezárult

  Vamikibart in Participants With Uveitic Macular Edema

  NCT05642325· 3. fázis· Hoffmann-La Roche· Forrás

• Leállították

  Study to Investigate the Long-term Safety of FAB122 in Patients With Amyotrophic Lateral Sclerosis

  NCT05866926· 3. fázis· Ferrer Internacional S.A.· Forrás

• Lezárult

  A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis

  NCT05695950· 2. fázis· Lakefront Biotherapeutics NV· Forrás

• Fut, nem toboroz

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás

• Leállították

  A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

  NCT05592275· 2. fázis· Eli Lilly and Company· Forrás

• Lezárult

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· 3. fázis· Bayer· Forrás

• Lezárult

  Investigation of the ALLEGRA THV System With a New Delivery System in Patients With Aortic Stenosis or Failed Surgical Bioprosthesis

  NCT05478161· NVT GmbH· Forrás

• Leállították

  A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients

  NCT06025110· 2. fázis· ITB-Med LLC· Forrás

• Leállították

  Study of M5049 in DM and PM Participants (NEPTUNIA)

  NCT05650567· 2. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Lezárult

  Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis

  NCT05184088· 3. fázis· Lantheus Germany GmbH· Forrás

• Lezárult

  A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolism in people with irregular and often rapid heartbeat (atrial fibrillation), and at risk for stroke

  NCT05643573· 3. fázis· Bayer AG· Forrás

• Lezárult

  Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)

  NCT05291091· 2. fázis· Edgewise Therapeutics, Inc.· Forrás

Showing 50 of 103.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Lupus (SLE)18 munka · 2 vizsgálat
• Amiotrófiás laterálszklerózis (ALS)16 munka · 15 vizsgálat
• Amiloidózis15 munka · 11 vizsgálat
• Idiopátiás tüdőfibrózis13 munka · 20 vizsgálat
• Bronchiectasis12 munka · 6 vizsgálat
• Myocarditis11 munka · 2 vizsgálat
• Giant cell arteritis7 munka · 0 vizsgálat
• Myasthenia gravis7 munka · 10 vizsgálat
• Spondylitis ankylopoetica (Bechterew-kór)7 munka · 0 vizsgálat
• Dilated cardiomyopathy7 munka · 5 vizsgálat
• ANCA-asszociált vasculitis5 munka · 1 vizsgálat
• Cushing's syndrome5 munka · 0 vizsgálat
• Alopecia areata4 munka · 1 vizsgálat
• Myotonic dystrophy3 munka · 0 vizsgálat